Cholesterol Testing Products And Services Market

By Product;

Testing Kits and Testing Strips

By Test;

High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests, and Others

By Application;

Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia, and Others

By End User;

Hospitals and Clinics, Diagnostic Laboratories, and Ambulatory Care Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn363828092 Published Date: June, 2025 Updated Date: July, 2025

Cholesterol Testing Products And Services Market Overview

Cholesterol Testing Products And Services Market (USD Million)

Cholesterol Testing Products And Services Market was valued at USD 24,540.95 million in the year 2024. The size of this market is expected to increase to USD 39,691.87 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Cholesterol Testing Products And Services Market

*Market size in USD million

CAGR 7.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.1 %
Market Size (2024)USD 24,540.95 Million
Market Size (2031)USD 39,691.87 Million
Market ConcentrationMedium
Report Pages337
24,540.95
2024
39,691.87
2031

Major Players

  • Quest Diagnostics Incorporated
  • Clinical Reference Laboratory Inc.
  • Randox Laboratories Ltd.
  • PTS DIAGNOSTICS
  • Hoffmann-La Roche AG
  • Cell Biolabs Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific
  • Alere Inc.
  • Eurofins Scientific

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Cholesterol Testing Products And Services Market

Fragmented - Highly competitive market without dominant players


The Cholesterol Testing Products and Services Market is experiencing significant growth due to the rising concerns surrounding cardiovascular diseases (CVD). As a leading contributor to global health issues, cholesterol-related complications have increased the demand for testing services. It is estimated that approximately 45% of adults worldwide are affected by high cholesterol, pushing the need for regular monitoring and diagnostic solutions.

Health Awareness and Preventive Care Drive Growth
Health awareness campaigns and the increasing trend toward preventive healthcare have contributed to a surge in cholesterol testing. More than 55% of individuals undergoing cholesterol testing are doing so as part of routine health check-ups or preventive care. This shift is pushing healthcare providers to enhance the accessibility and affordability of testing products and services.

Technological Advancements in Testing Devices
Technological innovations in cholesterol testing devices have contributed to the market's expansion. 40% of cholesterol testing is now conducted using home-based kits, reflecting the growing trend toward self-monitoring of health. These advancements, such as more accurate digital devices, are not only increasing the accuracy of cholesterol measurement but also offering consumers greater convenience.

Integration of Cholesterol Testing with Digital Health Platforms
The integration of cholesterol testing with digital health platforms is another factor driving market growth. Around 25% of cholesterol tests are now linked to mobile health applications that help patients track their cholesterol levels over time. This digital transformation supports better management of cholesterol levels, thus contributing to enhanced patient outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Test
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Cholesterol Testing Products And Services Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Preventive healthcare
        2. Cardiovascular risk
        3. Technological advancements
      2. Restraints
        1. Cost Constraints
        2. Limited Accessibility
        3. Technological Limitations
      3. Opportunities
        1. Point-of-Care
        2. Home Testing
        3. Technological Innovation
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cholesterol Testing Products And Services Market, By Product , 2021 - 2031 (USD Million)
      1. Testing Kits
      2. Testing Strips
    2. Cholesterol Testing Products And Services Market, By Test, 2021 - 2031 (USD Million)
      1. High Density Lipoprotein (HDL) Cholesterol Tests
      2. Low Density Lipoprotein (LDL) Cholesterol Tests
      3. Triglyceride Tests
      4. Others
    3. Cholesterol Testing Products And Services Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals and Clinics
      2. Diagnostic Laboratories
      3. Ambulatory Care Centers
    4. Cholesterol Testing Products And Services Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Quest Diagnostics Incorporated
      2. Clinical Reference Laboratory Inc.
      3. Randox Laboratories Ltd.
      4. PTS DIAGNOSTICS
      5. Hoffmann-La Roche AG
      6. Cell Biolabs Inc.
      7. Laboratory Corporation of America Holdings
      8. Thermo Fisher Scientific
      9. Alere Inc.
      10. Eurofins Scientific
  7. Analyst Views
  8. Future Outlook of the Market